Recurrent miscarriage is one of the most emotionally difficult fertility problems for couples, especially when pregnancy occurs but does not continue. In this situation, it is not enough to say “try again” without a structured evaluation. Recurrent pregnancy loss requires careful assessment of embryo genetics, uterine anatomy, hormones, blood-clotting immune factors, sperm quality, and the couple’s full reproductive history.
Recurrent miscarriage does not always mean that IVF is needed immediately. Some causes can be treated before a natural pregnancy, such as a uterine septum, intrauterine adhesions, thyroid disease, uncontrolled diabetes, or antiphospholipid syndrome. In other cases, especially when repeated losses are linked to chromosomal abnormalities, advanced maternal age, or a balanced chromosomal rearrangement in one partner, IVF with genetic testing of embryos may become an important option.
The purpose of advanced recurrent miscarriage testing is not to order every possible test. The goal is to choose tests that can change the treatment plan. A useful evaluation considers maternal age, number of losses, gestational age at each loss, whether fetal heartbeat was seen, whether pregnancy tissue was tested, previous live births, infertility history, ultrasound findings, menstrual history, and male factors.
What Is Recurrent Miscarriage?
Recurrent miscarriage, also called recurrent pregnancy loss, refers to repeated pregnancy losses before viability. Definitions vary between medical organizations, but many fertility specialists begin evaluation after two or more losses, especially if the losses are consecutive, clinically documented, or associated with specific risk factors.
A miscarriage may occur very early before a heartbeat, after a gestational sac is seen, after fetal heartbeat, or in the second trimester. Each pattern may suggest different causes, so accurate documentation of previous pregnancies is very important.
When should recurrent miscarriage testing begin?
Testing may begin after two or more pregnancy losses, especially if the woman is older, the losses occurred after heartbeat, there was a second-trimester loss, or there is a known family history of genetic or clotting disorders. Earlier evaluation may also be reasonable if the couple is already planning IVF or has limited time due to age or ovarian reserve.
Evaluation may be appropriate after:
- Two or more miscarriages.
- Loss after fetal heartbeat.
- Second-trimester pregnancy loss.
- Maternal age over 35.
- Previous chromosomal abnormality in pregnancy tissue.
- Family history of genetic disorders.
- Recurrent miscarriage after IVF.
- Autoimmune or clotting history.
- Suspected uterine abnormality.
- Infertility combined with pregnancy loss.
Waiting without evaluation can be emotionally difficult and may delay treatment of a correctable cause.
Is recurrent miscarriage the same as infertility?
No. Many couples with recurrent miscarriage can conceive, but the pregnancy does not continue. Infertility means difficulty achieving pregnancy, while recurrent miscarriage means difficulty maintaining pregnancy. However, both problems can occur together.
This distinction matters because treatment is different. In infertility, the main question is why pregnancy is not happening. In recurrent miscarriage, the main question is why pregnancy stops after it begins.
Read about: Differences Between IVF and ICSI Fertilization Techniques
Causes of Recurrent Miscarriage
Recurrent miscarriage has many possible causes. The most common cause of early pregnancy loss is chromosomal abnormality in the embryo, especially as maternal age increases. However, repeated losses require evaluation for other causes, including uterine abnormalities, thyroid disease, diabetes, antiphospholipid syndrome, parental chromosomal rearrangements, and selected male factors.
Sometimes all tests are normal. This is called unexplained recurrent miscarriage. It can be frustrating, but it does not mean there is no hope.
Genetic and chromosomal causes
Chromosomal abnormalities in the embryo are a major cause of early miscarriage. These may occur randomly due to errors in egg or sperm chromosome division. The risk increases with maternal age. In some couples, one partner carries a balanced translocation or chromosomal rearrangement that does not affect their own health but can lead to unbalanced embryos and repeated miscarriage.
Genetic evaluation may include:
- Genetic testing of pregnancy tissue.
- Chromosomal analysis of miscarriage tissue.
- Parental karyotype testing.
- Genetic counseling.
- Family history review.
- PGT-SR if a structural rearrangement is found.
- PGT-A in selected cases.
- Discussion of maternal age and egg quality.
- IVF planning based on expected embryo number.
- Counseling about normal and abnormal embryo rates.
Testing pregnancy tissue can be very informative because it helps distinguish embryo-related loss from losses that may require deeper maternal evaluation.
Uterine and endometrial causes
Uterine problems can contribute to recurrent miscarriage, especially when they affect the uterine cavity. Examples include uterine septum, adhesions, cavity-distorting fibroids, endometrial polyps, and congenital uterine anomalies.
Uterine evaluation may include:
- Transvaginal ultrasound.
- 3D ultrasound.
- Saline infusion sonography.
- Hysterosalpingography.
- Diagnostic hysteroscopy.
- Operative hysteroscopy if needed.
- Assessment of endometrial lining.
- Evaluation for adhesions.
- Fibroid and polyp assessment.
- Cervical evaluation in selected second-trimester losses.
If a correctable uterine cavity problem is found, treating it before the next pregnancy or embryo transfer may be more important than moving directly to IVF.
Read about: Step-by-Step Guide to the In Vitro Fertilization (IVF) Process
Advanced Testing for Recurrent Miscarriage
Advanced testing for recurrent miscarriage should be targeted, not random. Ordering too many unproven tests can create confusion, anxiety, and unnecessary treatment. A good plan is based on the woman’s age, pregnancy history, previous miscarriage results, and male partner evaluation.
The first goal is to identify causes that are treatable or that change the next pregnancy or IVF plan.
Blood, hormone, and clotting-immune tests
Blood testing can evaluate factors that affect pregnancy continuation, such as thyroid function, diabetes control, and antiphospholipid syndrome. Antiphospholipid syndrome is one of the better-established treatable causes of recurrent pregnancy loss.
Testing may include:
- TSH and thyroid evaluation.
- HbA1c for diabetes control.
- Prolactin when clinically indicated.
- Lupus anticoagulant.
- Anticardiolipin antibodies.
- Anti-beta-2 glycoprotein I antibodies.
- Complete blood count.
- Selected autoimmune evaluation when symptoms exist.
- Selected thrombophilia testing in specific cases.
- Vitamin and metabolic review when clinically relevant.
- Chronic disease assessment before pregnancy.
- Medication review.
Not every immune test advertised online is evidence-based. Treatments such as steroids, immune infusions, or anticoagulation should not be used without a clear indication.
Male factor and sperm quality testing
Although miscarriage occurs in the female body, the male partner can still contribute to embryo quality. Severe sperm abnormalities, oxidative stress, infections, varicocele, and high sperm DNA fragmentation may be relevant in selected cases.
Male evaluation may include:
- Semen analysis.
- Sperm concentration, motility, and morphology.
- Sperm DNA fragmentation testing in selected cases.
- Infection assessment when indicated.
- Varicocele evaluation.
- Smoking and lifestyle review.
- Heat and toxin exposure review.
- Diabetes and chronic disease review.
- Andrology consultation.
- Lifestyle optimization before IVF.
Sperm DNA fragmentation testing is not required for every couple, but it may be useful when losses continue despite good embryo appearance or when semen analysis is abnormal.
Read about: IVF Procedure Explained: From Fertilization to Embryo Transfer
Role of IVF in Recurrent Miscarriage
IVF is not the first solution for every recurrent miscarriage case. If the cause is thyroid disease, a uterine cavity defect, diabetes, or antiphospholipid syndrome, treating the cause may be more important. However, IVF becomes valuable when embryo genetics are suspected, maternal age is advanced, parental chromosomal rearrangement is present, or embryo testing is needed.
IVF allows embryos to be created in the laboratory, monitored, and sometimes genetically tested before transfer. It can reduce the chance of transferring chromosomally abnormal embryos in selected couples, but it cannot prevent every miscarriage.
When is IVF considered?
IVF may be considered when recurrent miscarriage is linked to embryo quality, chromosomal abnormalities, infertility, advanced maternal age, or genetic risk. It may also be considered when the couple wants embryo testing before transfer.
IVF may be suitable for:
- Advanced maternal age.
- Repeated chromosomal abnormalities in losses.
- Balanced translocation in one partner.
- Recurrent miscarriage with infertility.
- Severe male factor.
- Need for PGT-A or PGT-SR.
- Previous IVF miscarriages.
- Repeated embryo aneuploidy.
- Limited time due to ovarian reserve.
- Desire to reduce transfer of abnormal embryos.
However, if natural pregnancy chances are good and no embryo-related issue is suspected, a doctor may discuss expectant management and close early pregnancy monitoring instead.
PGT-A and PGT-SR embryo testing
PGT-A tests embryos for chromosomal copy number abnormalities. It may help select embryos that are more likely to continue developing, especially in selected older patients or those with repeated aneuploid losses. PGT-SR is used when one partner has a balanced translocation or structural rearrangement.
Embryo testing may help:
- Reduce transfer of chromosomally abnormal embryos.
- Select embryos with better continuation potential.
- Reduce miscarriage related to aneuploidy in selected cases.
- Support single embryo transfer.
- Guide treatment in chromosomal rearrangement carriers.
- Provide clearer reproductive planning.
- Reduce uncertainty after repeated losses.
- Help older patients prioritize embryos.
- Avoid transfer of embryos with major chromosomal imbalance.
- Support genetic counseling.
PGT-A does not guarantee a baby and does not prevent miscarriage from uterine, hormonal, clotting, or maternal medical causes. Its value depends on age, embryo number, laboratory quality, and the couple’s diagnosis.
Treatment Based on the Cause
Treatment for recurrent miscarriage should be cause-based. A common mistake is giving the same treatment to every patient, such as aspirin, heparin, steroids, progesterone, or IVF without a clear diagnosis. The right question is: What is the most likely cause, and does the treatment improve the chance of live birth?
Management may require collaboration between fertility specialists, genetic counselors, endocrinologists, hematologists, and high-risk pregnancy specialists.
Treatable causes
When a clear cause is found, it should be managed before the next pregnancy or embryo transfer. Uterine septum, adhesions, polyps, and cavity-distorting fibroids may need hysteroscopic treatment. Thyroid dysfunction and diabetes should be optimized. Antiphospholipid syndrome requires a specific medical plan.
Treatment may include:
- Hysteroscopic septum correction.
- Removal of uterine polyps.
- Treatment of adhesions.
- Management of cavity-distorting fibroids.
- Thyroid optimization before pregnancy.
- Diabetes control and HbA1c improvement.
- Antiphospholipid syndrome treatment.
- Aspirin and heparin when APS is diagnosed.
- Infection treatment when documented.
- Weight and metabolic optimization.
- Smoking cessation.
- Lifestyle improvement for both partners.
Treatment should be individualized and evidence-based.
Unexplained recurrent miscarriage
In some couples, testing does not reveal a clear cause. This is called unexplained recurrent miscarriage. It can be emotionally difficult, but many couples still have successful pregnancies later with supportive care and early monitoring.
A plan may include:
- Reviewing all previous test results.
- Testing pregnancy tissue if another loss occurs.
- Early ultrasound monitoring.
- Emotional support.
- Detailed uterine cavity assessment.
- Lifestyle optimization.
- Progesterone discussion in selected cases.
- IVF with PGT-A discussion if age or embryo risk suggests benefit.
- Avoiding unproven immune treatments.
- Clear early pregnancy follow-up plan.
Unexplained does not mean hopeless. It means treatment decisions must be especially careful.
Read about: IVF Procedure with Egg Freezing: Step-by-Step Explanation
IVF Plan After Recurrent Miscarriage
When IVF is chosen after recurrent miscarriage, the plan should be precise. The goal is not only to create embryos, but to transfer the right embryo into a well-prepared uterus. This requires ovarian reserve testing, semen evaluation, embryo culture planning, genetic testing when indicated, and uterine preparation.
The plan may differ depending on whether the transfer is fresh or frozen, whether embryos are tested, and whether a uterine or hormonal issue must be corrected first.
IVF steps with advanced testing
IVF in recurrent miscarriage cases usually begins with fertility assessment, ovarian stimulation, egg retrieval, fertilization, embryo culture, possible biopsy, genetic testing, freezing, and later embryo transfer.
Steps may include:
- AMH and ovarian reserve assessment.
- Antral follicle count ultrasound.
- Semen analysis.
- Stimulation protocol selection.
- Egg retrieval.
- ICSI when indicated.
- Embryo culture to blastocyst stage.
- Embryo biopsy when indicated.
- PGT-A or PGT-SR when appropriate.
- Embryo freezing.
- Frozen embryo transfer planning.
- Single embryo transfer in many cases.
Single embryo transfer can reduce multiple pregnancy risk and make pregnancy monitoring clearer.
Preparing the uterus before embryo transfer
A genetically suitable embryo is not enough if the uterus is not ready. Before embryo transfer, the doctor may evaluate the uterine cavity, especially if there were previous miscarriages, curettage procedures, adhesions, or suspected uterine pathology.
Before transfer, the doctor may assess:
- Endometrial thickness.
- Uterine cavity shape.
- Polyps.
- Adhesions.
- Uterine septum.
- Cavity-distorting fibroids.
- Progesterone timing.
- Thyroid function.
- Diabetes control.
- Anticoagulation plan if needed.
- Luteal phase support.
- Timing of embryo transfer.
Success depends on both embryo quality and uterine readiness.
Read about: Embryo Freezing in IVF: Key Benefits and Opportunities for Couples
Conclusion
Recurrent miscarriage requires a structured and compassionate evaluation. Advanced testing may include pregnancy tissue analysis, parental karyotypes, uterine cavity assessment, thyroid and diabetes evaluation, antiphospholipid antibody testing, and selected male factor testing. The goal is to identify whether the cause is embryo-related, uterine, hormonal, clotting-related, male-related, or unexplained.
IVF can be an important solution in selected cases, especially with advanced maternal age, repeated chromosomal abnormalities, parental chromosomal rearrangements, infertility, or need for PGT-A or PGT-SR. However, IVF is not a guaranteed cure for recurrent miscarriage and should not replace treatment of uterine, hormonal, or clotting causes when they exist.
Frequently Asked Questions: Recurrent Miscarriage and IVF
When is miscarriage considered recurrent?
Many specialists begin evaluation after two or more pregnancy losses, especially if they are clinically documented, consecutive, occurred after heartbeat, or happened at an older maternal age.
Can IVF prevent recurrent miscarriage?
Not always. IVF with embryo testing may reduce transfer of chromosomally abnormal embryos in selected cases, but it cannot prevent miscarriage caused by uterine, hormonal, clotting, or maternal health problems.
What is the most important test after miscarriage?
Genetic testing of pregnancy tissue can be very useful when available, because it helps determine whether the loss was likely due to an embryo chromosomal problem.
Should the male partner be tested?
Yes, in selected cases. Semen analysis is often useful, and sperm DNA fragmentation testing may be considered when there are repeated losses or abnormal semen findings.
What if all recurrent miscarriage tests are normal?
This is called unexplained recurrent miscarriage. Many couples still succeed later with supportive care, early monitoring, and carefully selected treatment options.
